IDEXX Laboratories Inc
NASDAQ:IDXX

Watchlist Manager
IDEXX Laboratories Inc Logo
IDEXX Laboratories Inc
NASDAQ:IDXX
Watchlist
Price: 414.52 USD -0.66% Market Closed
Market Cap: 34.1B USD
Have any thoughts about
IDEXX Laboratories Inc?
Write Note

Intrinsic Value

The intrinsic value of one IDXX stock under the Base Case scenario is 254.3 USD. Compared to the current market price of 414.52 USD, IDEXX Laboratories Inc is Overvalued by 39%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IDXX Intrinsic Value
254.3 USD
Overvaluation 39%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
IDEXX Laboratories Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for IDXX cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about IDXX?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about IDEXX Laboratories Inc

Provide an overview of the primary business activities
of IDEXX Laboratories Inc.

What unique competitive advantages
does IDEXX Laboratories Inc hold over its rivals?

What risks and challenges
does IDEXX Laboratories Inc face in the near future?

Has there been any significant insider trading activity
in IDEXX Laboratories Inc recently?

Summarize the latest earnings call
of IDEXX Laboratories Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for IDEXX Laboratories Inc.

Provide P/S
for IDEXX Laboratories Inc.

Provide P/E
for IDEXX Laboratories Inc.

Provide P/OCF
for IDEXX Laboratories Inc.

Provide P/FCFE
for IDEXX Laboratories Inc.

Provide P/B
for IDEXX Laboratories Inc.

Provide EV/S
for IDEXX Laboratories Inc.

Provide EV/GP
for IDEXX Laboratories Inc.

Provide EV/EBITDA
for IDEXX Laboratories Inc.

Provide EV/EBIT
for IDEXX Laboratories Inc.

Provide EV/OCF
for IDEXX Laboratories Inc.

Provide EV/FCFF
for IDEXX Laboratories Inc.

Provide EV/IC
for IDEXX Laboratories Inc.

Show me price targets
for IDEXX Laboratories Inc made by professional analysts.

What are the Revenue projections
for IDEXX Laboratories Inc?

How accurate were the past Revenue estimates
for IDEXX Laboratories Inc?

What are the Net Income projections
for IDEXX Laboratories Inc?

How accurate were the past Net Income estimates
for IDEXX Laboratories Inc?

What are the EPS projections
for IDEXX Laboratories Inc?

How accurate were the past EPS estimates
for IDEXX Laboratories Inc?

What are the EBIT projections
for IDEXX Laboratories Inc?

How accurate were the past EBIT estimates
for IDEXX Laboratories Inc?

Compare the revenue forecasts
for IDEXX Laboratories Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of IDEXX Laboratories Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of IDEXX Laboratories Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of IDEXX Laboratories Inc compared to its peers.

Compare the P/E ratios
of IDEXX Laboratories Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing IDEXX Laboratories Inc with its peers.

Analyze the financial leverage
of IDEXX Laboratories Inc compared to its main competitors.

Show all profitability ratios
for IDEXX Laboratories Inc.

Provide ROE
for IDEXX Laboratories Inc.

Provide ROA
for IDEXX Laboratories Inc.

Provide ROIC
for IDEXX Laboratories Inc.

Provide ROCE
for IDEXX Laboratories Inc.

Provide Gross Margin
for IDEXX Laboratories Inc.

Provide Operating Margin
for IDEXX Laboratories Inc.

Provide Net Margin
for IDEXX Laboratories Inc.

Provide FCF Margin
for IDEXX Laboratories Inc.

Show all solvency ratios
for IDEXX Laboratories Inc.

Provide D/E Ratio
for IDEXX Laboratories Inc.

Provide D/A Ratio
for IDEXX Laboratories Inc.

Provide Interest Coverage Ratio
for IDEXX Laboratories Inc.

Provide Altman Z-Score Ratio
for IDEXX Laboratories Inc.

Provide Quick Ratio
for IDEXX Laboratories Inc.

Provide Current Ratio
for IDEXX Laboratories Inc.

Provide Cash Ratio
for IDEXX Laboratories Inc.

What is the historical Revenue growth
over the last 5 years for IDEXX Laboratories Inc?

What is the historical Net Income growth
over the last 5 years for IDEXX Laboratories Inc?

What is the current Free Cash Flow
of IDEXX Laboratories Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for IDEXX Laboratories Inc.

Business Breakdown

IDEXX Laboratories Inc. is a leading global provider of veterinary diagnostic products and services, dedicated to enhancing the health and well-being of pets worldwide. Founded in 1983, the company has established itself as an innovator in the animal healthcare market, offering a comprehensive range of diagnostic tests, equipment, and software that empower veterinarians to make informed decisions. With a consistent focus on research and development, IDEXX has expanded its portfolio to include cutting-edge solutions such as digital imaging and telemedicine, addressing the growing needs of the pet care industry. Their strategic partnerships and robust distribution channels further bolster thei...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
IDEXX Laboratories Inc

Current Assets 1.4B
Cash & Short-Term Investments 308.6m
Receivables 511.3m
Other Current Assets 613.9m
Non-Current Assets 1.9B
PP&E 717.7m
Other Non-Current Assets 1.2B
Current Liabilities 1B
Accounts Payable 110.6m
Accrued Liabilities 511m
Short-Term Debt 250m
Other Current Liabilities 137.6m
Non-Current Liabilities 723.5m
Long-Term Debt 524.8m
Other Non-Current Liabilities 198.7m
Efficiency

Earnings Waterfall
IDEXX Laboratories Inc

Revenue
3.8B USD
Cost of Revenue
-1.5B USD
Gross Profit
2.3B USD
Operating Expenses
-1.2B USD
Operating Income
1.1B USD
Other Expenses
-245.7m USD
Net Income
866.2m USD

Free Cash Flow Analysis
IDEXX Laboratories Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In Q3 2024, IDEXX Laboratories experienced a 6% organic revenue increase, with a notable 13% growth in its water business. Although the CAG Diagnostics segment showed organic growth of 7%, overall growth was moderated by U.S. macroeconomic pressures, leading to an updated organic growth guidance of 5.3% to 6% for the full year. The EPS rose to $2.80, marking an 11% increase. Looking forward, IDEXX expects Q4 revenue growth of approximately 3% and CAG Diagnostic recurring revenue growth of 3.5% to 4%. Their innovative product, the inVue Dx Analyzer, has garnered nearly 700 pre-orders, signaling strong future demand.

What is Earnings Call?
Fundamental Scores

IDXX Profitability Score
Profitability Due Diligence

IDEXX Laboratories Inc's profitability score is 74/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional 3-Year Average ROIC
Positive Gross Profit
Positive Free Cash Flow
74/100
Profitability
Score

IDEXX Laboratories Inc's profitability score is 74/100. The higher the profitability score, the more profitable the company is.

IDXX Solvency Score
Solvency Due Diligence

IDEXX Laboratories Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
65/100
Solvency
Score

IDEXX Laboratories Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IDXX Price Targets Summary
IDEXX Laboratories Inc

Wall Street analysts forecast IDXX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IDXX is 544.69 USD with a low forecast of 409.17 USD and a high forecast of 637.35 USD.

Lowest
Price Target
409.17 USD
1% Downside
Average
Price Target
544.69 USD
31% Upside
Highest
Price Target
637.35 USD
54% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for IDXX?

Click here to dive deeper.

Dividends

IDEXX Laboratories Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for IDXX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

IDXX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

IDXX News

Other Videos

Profile

IDEXX Laboratories Inc Logo
IDEXX Laboratories Inc

Country

United States of America

Industry

Health Care

Market Cap

34.1B USD

Dividend Yield

0%

Description

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 10,350 full-time employees. The company also offers human medical point-of-care & laboratory diagnostics. Its products include health monitoring, others. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment CAG develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. The Water segment develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services that are used to manage the health status of livestock and poultry.

Contact

MAINE
Westbrook
1 Idexx Dr
+12075560300.0
www.idexx.com

IPO

1991-06-21

Employees

10 350

Officers

President, CEO & Director
Mr. Jonathan J. Mazelsky
CFO, Executive VP & Treasurer
Mr. Brian P. McKeon
Executive VP and GM of Reference Laboratories & Information Technology
Mr. Michael J. Lane
Senior Vice President of Global Operations
Mr. John Hart
Senior Vice President of Commercial Finance & Sales Operations
Mr. Jeffery D. Chadbourne
Executive VP & CTO
Dr. Martin Smith Ph.D.
Show More
Senior VP & Chief Information Officer
Mr. Ken Grady
Executive VP, General Counsel, & Corporate Secretary
Ms. Sharon E. Underberg
Executive VP & Chief Human Resources Officer
Mr. Michael P. Johnson
Senior VP & Chief Revenue Officer
Mr. George J. Fennell
Show Less

See Also

Discover More
What is the Intrinsic Value of one IDXX stock?

The intrinsic value of one IDXX stock under the Base Case scenario is 254.3 USD.

Is IDXX stock undervalued or overvalued?

Compared to the current market price of 414.52 USD, IDEXX Laboratories Inc is Overvalued by 39%.

Back to Top